Startsida4DX • ASX
add
4DMedical Ltd
Föregående stängning
0,28 $
Dygnsintervall
0,28 $ - 0,29 $
Årsintervall
0,23 $ - 0,72 $
Börsvärde
126,12 mn AUD
Genomsnittlig volym
948,52 tn
P/E-tal
-
Direktavkastning
-
Primär börs
ASX
Aktuellt
Ekonomi
Resultaträkning
Intäkter
Nettoinkomst
(AUD) | dec. 2024info | Förändring Y/Y |
---|---|---|
Intäkter | 1,45 mn | 265,33 % |
Rörliga kostnader | 13,10 mn | 7,86 % |
Nettoinkomst | −9,58 mn | −22,82 % |
Nettovinstmarginal | −662,04 | 66,38 % |
Vinst per aktie | — | — |
EBITDA | −11,23 mn | −1,87 % |
Giltig skattesats | −0,04 % | — |
Balansräkning
Totala tillgångar
Totala ansvarsskyldigheter
(AUD) | dec. 2024info | Förändring Y/Y |
---|---|---|
Kontanta och kortsiktiga investeringar | 15,95 mn | −66,68 % |
Totala tillgångar | 102,01 mn | −29,03 % |
Totala ansvarsskyldigheter | 42,15 mn | −19,87 % |
Totala tillgångar | 59,86 mn | — |
Utestående aktier | 413,32 mn | — |
P/B | 2,04 | — |
Avkastning på tillgångar | −28,80 % | — |
Avkastning på kapital | −45,42 % | — |
Kassaflöde
Förändring i nettokassa
(AUD) | dec. 2024info | Förändring Y/Y |
---|---|---|
Nettoinkomst | −9,58 mn | −22,82 % |
Kontanter från verksamhet | −7,07 mn | 4,01 % |
Kontanter från investering | −422,55 tn | 97,85 % |
Kontanter från finansiering | 170,01 tn | −98,95 % |
Förändring i nettokassa | −7,33 mn | 32,46 % |
Fritt kassaflöde | −6,17 mn | 4,49 % |
Om
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Grundades
2013
Hemsida
Anställda
145